Syndax Pharmaceuticals, Inc. (SNDX)
23.81
-0.52
(-2.14%)
USD |
NASDAQ |
Apr 16, 16:00
23.80
-0.01
(-0.04%)
After-Hours: 20:00
Syndax Pharmaceuticals Research and Development Expense (Quarterly) : 78.64M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 74.38M |
| Vera Therapeutics, Inc. | 59.18M |
| Biogen, Inc. | 434.00M |
| Johnson & Johnson | 3.527B |
| Tango Therapeutics, Inc. | 31.62M |